Graf Acquisition Corp. IV (GFOR) Closes NKGen Biotech Deal
Graf Acquisition Corp. IV (NYSE:GFOR) has closed its combination with NKGen Biotech and its shares and warrants will begin trading on the Nasdaq under the symbols “NKGN” and “NKGNW” today.
The SPAC secured shareholder approval for the deal last week with 84.3% redemptions. ...READ MORE
